Andrew F Leuchter

Title(s)Professor, Psychiatry and Biobehavioral Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Network-targeted theta-burst stimulation for episodic memory improvement in mild cognitive impairment
    NIH R01AG068317Sep 15, 2020 - Apr 30, 2025
    Role: Co-Principal Investigator
    UCLA Clinical Pharmacology Training Program
    NIH T32GM075776Jul 1, 2006 - Jun 30, 2018
    Role: Co-Principal Investigator
    Psychobiologic Factors of the Placebo Response in MDD
    NIH R01AT002479Sep 29, 2004 - Jun 30, 2009
    Role: Principal Investigator
    ENHANCING TREATMENT OUTCOMES IN DEPRESSION
    NIH K02MH001165Dec 1, 1994 - Nov 30, 2005
    Role: Principal Investigator
    GERIATRIC MENTAL HEALTH ACADEMIC AWARD
    NIH K07MH000665Aug 1, 1986 - Jul 31, 1989
    Role: Principal Investigator
    MENTAL ILLNESS IN THE ELDERLY--DIAGNOSTIC TESTING
    NIH R01MH040705Mar 1, 1986 - Jun 30, 2001
    Role: Principal Investigator
    Research Training: Psychobiological Sciences
    NIH T32MH017140Sep 30, 1983 - Jun 30, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reminder-Focused Positive Psychiatry: Suicide Prevention Among Youths With Comorbid Posttraumatic Stress Disorder and Suicidality. Am J Psychother. 2022 Jul 29; appipsychotherapy20200061. Ahmadi N, Pynoos R, Leuchter A, Kopelowicz A. PMID: 35903914.
      View in: PubMed   Mentions:    Fields:    
    2. Sequential Prefrontal and Temporoparietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment of Tinnitus With and Without Comorbid Depression: A Case Series and Systematic Review. Front Neurol. 2022; 13:831832. Marder KG, Cho J, Chincanchan R, Wilson AC, Corlier J, Krantz DE, Ginder ND, Lee JC, Wilke SA, Tadayonnejad R, Levitt J, Ishiyama A, Leuchter MK, Leuchter AF. PMID: 35665054; PMCID: PMC9160187.
      View in: PubMed   Mentions:
    3. Psychostimulant use and clinical outcome of repetitive transcranial magnetic stimulation treatment of major depressive disorder. Depress Anxiety. 2022 05; 39(5):397-406. Wilke SA, Johnson CL, Corlier J, Marder KG, Wilson AC, Pleman CM, Leuchter AF. PMID: 35389536.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Treatment of Spider Phobia Using Repeated Exposures and Adjunctive Repetitive Transcranial Magnetic Stimulation: A Proof-of-Concept Study. Front Psychiatry. 2022; 13:823158. Leuchter MK, Rosenberg BM, Schapira G, Wong NR, Leuchter AF, McGlade AL, Krantz DE, Ginder ND, Lee JC, Wilke SA, Tadayonnejad R, Levitt J, Marder KG, Craske MG, Iacoboni M. PMID: 35370840; PMCID: PMC8965447.
      View in: PubMed   Mentions:
    5. Absence of early mood improvement as a robust predictor of rTMS nonresponse in major depressive disorder. Depress Anxiety. 2022 02; 39(2):123-133. Mirman AM, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Ojha R, Daskalakis ZJ, Leuchter AF, Lee JC. PMID: 34990046.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Novel method for identification of individualized resonant frequencies for treatment of Major Depressive Disorder (MDD) using repetitive Transcranial Magnetic Stimulation (rTMS): A proof-of-concept study. Brain Stimul. 2021 Sep-Oct; 14(5):1373-1383. Leuchter AF, Wilson AC, Vince-Cruz N, Corlier J. PMID: 34425244.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Can excitatory neuromodulation change distorted perception of one's appearance? Brain Stimul. 2021 Sep-Oct; 14(5):1197-1200. Wong WW, Rangaprakash D, Larson MS, Diaz-Fong JP, Tadayonnejad R, Leuchter AF, Feusner JD. PMID: 34339891; PMCID: PMC9007239.
      View in: PubMed   Mentions: 1     Fields:    
    8. Subthreshold stimulation intensity is associated with greater clinical efficacy of intermittent theta-burst stimulation priming for Major Depressive Disorder. Brain Stimul. 2021 Jul-Aug; 14(4):1015-1021. Lee JC, Corlier J, Wilson AC, Tadayonnejad R, Marder KG, Ngo D, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. PMID: 34186465.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Repetitive transcranial magnetic stimulation treatment of major depressive disorder and comorbid chronic pain: response rates and neurophysiologic biomarkers. Psychol Med. 2021 Jun 22; 1-10. Corlier J, Tadayonnejad R, Wilson AC, Lee JC, Marder KG, Ginder ND, Wilke SA, Levitt J, Krantz D, Leuchter AF. PMID: 34154683.
      View in: PubMed   Mentions: 2     Fields:    
    10. Mentalizing imagery therapy for depressed family dementia caregivers: Feasibility, clinical outcomes and brain connectivity changes. J Affect Disord Rep. 2021 Jul; 5. Jain FA, Chernyak S, Nickerson L, Abrams M, Iacoboni M, Christov-Moore L, Connolly CG, Fisher LB, Sakurai H, Bentley K, Tan E, Pittman M, Lavretsky H, Leuchter AF. PMID: 34498016; PMCID: PMC8423372.
      View in: PubMed   Mentions: 3  
    11. Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis. Transl Psychiatry. 2021 05 28; 11(1):330. Voigt JD, Leuchter AF, Carpenter LL. PMID: 34050123; PMCID: PMC8163818.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Resting EEG theta connectivity and alpha power to predict repetitive transcranial magnetic stimulation response in depression: A non-replication from the ICON-DB consortium. Clin Neurophysiol. 2021 02; 132(2):650-659. Bailey NW, Krepel N, van Dijk H, Leuchter AF, Vila-Rodriguez F, Blumberger DM, Downar J, Wilson A, Daskalakis ZJ, Carpenter LL, Corlier J, Arns M, Fitzgerald PB. PMID: 33223495.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Individual alpha frequency proximity associated with repetitive transcranial magnetic stimulation outcome: An independent replication study from the ICON-DB consortium. Clin Neurophysiol. 2021 02; 132(2):643-649. Roelofs CL, Krepel N, Corlier J, Carpenter LL, Fitzgerald PB, Daskalakis ZJ, Tendolkar I, Wilson A, Downar J, Bailey NW, Blumberger DM, Vila-Rodriguez F, Leuchter AF, Arns M. PMID: 33243617.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Sequential multi-locus transcranial magnetic stimulation for treatment of obsessive-compulsive disorder with comorbid major depression: A case series. Brain Stimul. 2020 Nov - Dec; 13(6):1600-1602. Tadayonnejad R, Wilson AC, Corlier J, Lee JC, Ginder ND, Levitt JG, Wilke SA, Marder KG, Krantz D, Bari AA, Feusner JD, Pouratian N, Leuchter AF. PMID: 33065361.
      View in: PubMed   Mentions: 2     Fields:    
    15. Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder. J Affect Disord. 2020 12 01; 277:964-969. Lee JC, Wilson AC, Corlier J, Tadayonnejad R, Marder KG, Pleman CM, Krantz DE, Wilke SA, Levitt JG, Ginder ND, Leuchter AF. PMID: 33065840.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. EEG multifractal analysis correlates with cognitive testing scores and clinical staging in mild cognitive impairment. J Clin Neurosci. 2020 Jun; 76:195-200. Zorick T, Landers J, Leuchter A, Mandelkern MA. PMID: 32307299.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. EEG Spectral Features in Sleep of Autism Spectrum Disorders in Children with Tuberous Sclerosis Complex. J Autism Dev Disord. 2020 Mar; 50(3):916-923. Cook IA, Wilson AC, Peters JM, Goyal MN, Bebin EM, Northrup H, Krueger D, Leuchter AF, Sahin M, TACERN Study Group. PMID: 31811616.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. J Psychiatr Res. 2020 05; 124:159-165. Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. PMID: 32169689; PMCID: PMC7141143.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Benzodiazepine Use and rTMS Outcome. Am J Psychiatry. 2020 02 01; 177(2):172. Hunter AM, Leuchter AF. PMID: 32008397.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Effect of repetitive transcranial magnetic stimulation (rTMS) treatment of major depressive disorder (MDD) on cognitive control. J Affect Disord. 2020 03 15; 265:272-277. Corlier J, Burnette E, Wilson AC, Lou JJ, Landeros A, Minzenberg MJ, Leuchter AF. PMID: 32090751.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cereb Cortex. 2019 12 17; 29(12):4958-4967. Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. PMID: 30953441; PMCID: PMC7305800.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy J Psychiatry Neurosci. 2019 Nov 01; 44(6):386-394. Levitt JG, Kalender G, O’Neill J, Diaz JP, Cook IA, Ginder N, Krantz D, Minzenberg MJ, Vince-Cruz N, Nguyen LD, Alger JR, Leuchter AF. PMID: 31199104; PMCID: PMC6821508.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    23. Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. Front Genet. 2019; 10:870. Cook IA, Congdon E, Krantz DE, Hunter AM, Coppola G, Hamilton SP, Leuchter AF. PMID: 31620172; PMCID: PMC6760033.
      View in: PubMed   Mentions: 1  
    24. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD). Brain Stimul. 2019 Nov - Dec; 12(6):1572-1578. Corlier J, Carpenter LL, Wilson AC, Tirrell E, Gobin AP, Kavanaugh B, Leuchter AF. PMID: 31378603.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    25. Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex. Epilepsia. 2019 08; 60(8):1721-1732. Davis PE, Kapur K, Filip-Dhima R, Trowbridge SK, Little E, Wilson A, Leuchter A, Bebin EM, Krueger D, Northrup H, Wu JY, Sahin M, Peters JM, Tuberous Sclerosis Autism Centers of Excellence Research Network. PMID: 31297797; PMCID: PMC6687536.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    26. Grief, Mindfulness and Neural Predictors of Improvement in Family Dementia Caregivers. Front Hum Neurosci. 2019; 13:155. Jain FA, Connolly CG, Moore LC, Leuchter AF, Abrams M, Ben-Yelles RW, Chang SE, Ramirez Gomez LA, Huey N, Lavretsky H, Iacoboni M. PMID: 31156412; PMCID: PMC6530345.
      View in: PubMed   Mentions: 3  
    27. The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: Implications for psychiatric treatment. J Affect Disord. 2019 06 15; 253:126-140. Minzenberg MJ, Leuchter AF. PMID: 31035213.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain Behav. 2019 05; 9(5):e01275. Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. PMID: 30941915; PMCID: PMC6520297.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    29. Double-Blind, Sham-Controlled, Pilot Study of Trigeminal Nerve Stimulation for Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019 04; 58(4):403-411.e3. McGough JJ, Sturm A, Cowen J, Tung K, Salgari GC, Leuchter AF, Cook IA, Sugar CA, Loo SK. PMID: 30768393; PMCID: PMC6481187.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    30. Brain Activity and Clinical Outcomes in Adults With Depression Treated With Synchronized Transcranial Magnetic Stimulation: An Exploratory Study. Neuromodulation. 2019 Dec; 22(8):894-897. Cook IA, Wilson AC, Corlier J, Leuchter AF. PMID: 30637862.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    31. A systematic literature review of the clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in non-treatment resistant patients with major depressive disorder. BMC Psychiatry. 2019 01 08; 19(1):13. Voigt J, Carpenter L, Leuchter A. PMID: 30621636; PMCID: PMC6325728.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    32. Predictors of response to synchronized transcranial magnetic stimulation for major depressive disorder. Depress Anxiety. 2019 03; 36(3):278-285. Philip NS, Leuchter AF, Cook IA, Massaro J, Goethe JW, Carpenter LL. PMID: 30480860.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    33. A precision medicine approach to repetitive Transcranial Magnetic Stimulation (rTMS). Brain Stimul. 2018 May - Jun; 11(3):463-464. Leuchter AF, Corlier J. PMID: 29501433.
      View in: PubMed   Mentions: 2     Fields:    
    34. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clin EEG Neurosci. 2018 Sep; 49(5):306-315. Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. PMID: 29224411.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    35. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis. PLoS One. 2017; 12(10):e0186950. Voigt J, Carpenter L, Leuchter A. PMID: 29073256; PMCID: PMC5658110.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    36. Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography. Breast Cancer Res Treat. 2017 Nov; 166(1):157-166. Van Dyk K, Hunter AM, Ercoli L, Petersen L, Leuchter AF, Ganz PA. PMID: 28707203.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Defining Treatment-Resistant Depression. JAMA Psychiatry. 2017 07 01; 74(7):758-759. Fogelson DL, Leuchter A. PMID: 28564677.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? Int Rev Psychiatry. 2017 04; 29(2):98-114. Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. PMID: 28362541.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    39. Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? Front Neurol. 2017; 8:91. Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF. PMID: 28424652; PMCID: PMC5371600.
      View in: PubMed   Mentions: 7  
    40. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. J Psychiatr Res. 2017 01; 84:174-183. Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA. PMID: 27770740.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    41. Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder. Clin EEG Neurosci. 2017 May; 48(3):159-167. Scanlon GC, Jain FA, Hunter AM, Cook IA, Leuchter AF. PMID: 27000108.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future. Prog Neuropsychopharmacol Biol Psychiatry. 2016 10 03; 70:170-218. Koek RJ, Schwartz HN, Scully S, Langevin JP, Spangler S, Korotinsky A, Jou K, Leuchter A. PMID: 26854815.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    43. Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder. Neuromodulation. 2016 Apr; 19(3):299-305. Cook IA, Abrams M, Leuchter AF. PMID: 26818103.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Authors' reply. Br J Psychiatry. 2015 Dec; 207(6):561-2. Leuchter AF, Hunter AM, Tartter M, Cook IA. PMID: 26628700.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology (Berl). 2015 Oct; 232(20):3833-40. Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF. PMID: 26319158.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    46. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015 Jul-Aug; 8(4):787-94. Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O'Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS. PMID: 26143022.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    47. Author's reply: To PMID 25213159. Br J Psychiatry. 2015 May; 206(5):435. Leuchter AF, Hunter AM, Tartter M, Cook IA. PMID: 25934309.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    48. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Ann N Y Acad Sci. 2015 May; 1344:78-91. Leuchter AF, Hunter AM, Krantz DE, Cook IA. PMID: 25809789; PMCID: PMC4412810.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    49. Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. Psychooncology. 2015 Nov; 24(11):1360-7. Ercoli LM, Petersen L, Hunter AM, Castellon SA, Kwan L, Kahn-Mills BA, Embree LM, Cernin PA, Leuchter AF, Ganz PA. PMID: 25759235.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    50. A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. J Clin Psychiatry. 2015 Mar; 76(3):327. Jain FA, Hunter AM, Leuchter AF, Brooks JO. PMID: 25830451.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues Clin Neurosci. 2014 Dec; 16(4):525-37. Leuchter AF, Hunter AM, Krantz DE, Cook IA. PMID: 25733956; PMCID: PMC4336921.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    52. An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder. Brain Stimul. 2015 Mar-Apr; 8(2):299-304. McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA. PMID: 25533244.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    53. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clin EEG Neurosci. 2015 Oct; 46(4):277-84. Caudill MM, Hunter AM, Cook IA, Leuchter AF. PMID: 25258429.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    54. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. Br J Psychiatry. 2014 Dec; 205(6):443-9. Leuchter AF, Hunter AM, Tartter M, Cook IA. PMID: 25213159; PMCID: PMC4248233.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    55. Heart rate variability and treatment outcome in major depression: a pilot study. Int J Psychophysiol. 2014 Aug; 93(2):204-10. Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D. PMID: 24769434.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    56. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. J Psychiatr Res. 2014 Jul; 54:11-8. Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. PMID: 24726639.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    57. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? J Psychiatr Res. 2014 Jun; 53:69-75. Cook IA, Hunter AM, Korb AS, Leuchter AF. PMID: 24630467; PMCID: PMC6333308.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    58. Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology. 2014 Jun; 23(6):713-5. Hunter AM, Kwan L, Ercoli LM, Mills BK, Cook IA, Ganz PA, Leuchter AF. PMID: 24890579.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    59. Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurg Clin N Am. 2014 Jan; 25(1):103-16. Cook IA, Espinoza R, Leuchter AF. PMID: 24262903.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    60. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav. 2013 Dec; 7(4):543-53. Ercoli LM, Castellon SA, Hunter AM, Kwan L, Kahn-Mills BA, Cernin PA, Leuchter AF, Ganz PA. PMID: 23955490.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    61. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Med Hypotheses. 2013 Dec; 81(6):1004-11. Hunter AM, Cook IA, Abrams M, Leuchter AF. PMID: 24112999.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    62. Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy Behav. 2013 Aug; 28(2):221-6. Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF. PMID: 23773978.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    63. A genome-wide association study of a sustained pattern of antidepressant response. J Psychiatr Res. 2013 Sep; 47(9):1157-65. Hunter AM, Leuchter AF, Power RA, Muthén B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP. PMID: 23726668; PMCID: PMC3710535.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    64. The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Front Hum Neurosci. 2013; 7:37. Leuchter AF, Cook IA, Jin Y, Phillips B. PMID: 23550274; PMCID: PMC3581824.
      View in: PubMed   Mentions: 34  
    65. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part I: Cross-Sectional and Longitudinal Assessment of Patients With Dementia. Am J Geriatr Psychiatry. 1994 Summer; 2(3):200-209. Leuchter A, Simon SL, Daly KA, Rosenberg-Thompson S, Abrams M, Dunkin JJ, Cook IA, Newton TF, Walter DO, Cummings JL. PMID: 28530933.
      View in: PubMed   Mentions:    Fields:    
    66. Quantitative EEG Correlates of Outcome in Older Psychiatric Patients: Part II: Two-Year Follow-Up of Patients With Depression. Am J Geriatr Psychiatry. 1994 Autumn; 2(4):290-299. Leuchter A, Simon SL, Daly KA, Abrams M, Rosenberg-Thompson S, Dunkin JJ, Cook IA, Newton TF, Spar JE. PMID: 28530979.
      View in: PubMed   Mentions: 2     Fields:    
    67. Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety. 2013 Jul; 30(7):624-30. Jain FA, Hunter AM, Brooks JO, Leuchter AF. PMID: 23288666.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    68. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? J Neuropsychiatry Clin Neurosci. 2013; 25(2):126-33. Hunter AM, Korb AS, Cook IA, Leuchter AF. PMID: 23686030.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    69. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry. 2013 Jan; 74(1):51-6. Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. PMID: 23419226.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    70. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. J Psychopharmacol. 2012 Aug; 26(8):1162-3; author reply 1164. Leuchter A, Cook IA, Hunter AM. PMID: 22807041.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    71. Does prior antidepressant treatment of major depression impact brain function during current treatment? Eur Neuropsychopharmacol. 2012 Oct; 22(10):711-20. Hunter AM, Cook IA, Leuchter AF. PMID: 22445212.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    72. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. PLoS One. 2012; 7(2):e32508. Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. PMID: 22384265; PMCID: PMC3286480.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    73. Effects of heart disease on depression treatment: results from the COMED study. Gen Hosp Psychiatry. 2012 Jan-Feb; 34(1):24-34. Kerber KB, Wisniewski SR, Luther JF, Leuchter AF, D'Empaire I, Trivedi MH, Rush AJ. PMID: 22001552.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    74. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. J Clin Neurophysiol. 2011 Oct; 28(5):478-82. Hunter AM, Cook IA, Greenwald SD, Tran ML, Miyamoto KN, Leuchter AF. PMID: 21946361; PMCID: PMC3188349.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    75. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Res. 2011 Jun 30; 192(3):188-94. Korb AS, Hunter AM, Cook IA, Leuchter AF. PMID: 21546222; PMCID: PMC3152489.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    76. Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychol Methods. 2011 Mar; 16(1):17-33. Muthén B, Asparouhov T, Hunter AM, Leuchter AF. PMID: 21381817; PMCID: PMC3060937.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    77. Evaluation of quantitative EEG by classification and regression trees to characterize responders to antidepressant and placebo treatment. Open Med Inform J. 2011; 5:1-8. Rabinoff M, Kitchen CM, Cook IA, Leuchter AF. PMID: 21603560; PMCID: PMC3097432.
      View in: PubMed   Mentions: 7  
    78. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. J Clin Psychopharmacol. 2010 Dec; 30(6):748-51. Hunter AM, Cook IA, Leuchter AF. PMID: 21057245.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    79. Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatr Scand. 2010 Dec; 122(6):461-9. Hunter AM, Leuchter AF, Cook IA, Abrams M. PMID: 20384600.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    80. Biomarkers to predict antidepressant response. Curr Psychiatry Rep. 2010 Dec; 12(6):553-62. Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD. PMID: 20963521; PMCID: PMC2965366.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    81. QEEG Measures in Huntington's Disease: A Pilot Study. PLoS Curr. 2010 Oct 25; 2:RRN1192. Hunter A, Bordelon Y, Cook I, Leuchter A. PMID: 21037796; PMCID: PMC2964156.
      View in: PubMed   Mentions: 10  
    82. Early adverse events and attrition in selective serotonin reuptake inhibitor treatment: a suicide assessment methodology study report. J Clin Psychopharmacol. 2010 Jun; 30(3):259-66. Warden D, Trivedi MH, Wisniewski SR, Kurian B, Zisook S, Kornstein SG, Friedman ES, Miyahara S, Leuchter AF, Fava M, Rush AJ. PMID: 20473060; PMCID: PMC3119579.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    83. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol. 2010 Apr; 30(2):193-7. Kobak KA, Leuchter A, DeBrota D, Engelhardt N, Williams JB, Cook IA, Leon AC, Alpert J. PMID: 20520295.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    84. Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clin EEG Neurosci. 2010 Jan; 41(1):19-23. Farahbod H, Cook IA, Korb AS, Hunter AM, Leuchter AF. PMID: 20307012.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res. 2009 Nov 30; 174(2):152-7. Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. PMID: 19853417; PMCID: PMC2804067.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    86. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 2009 Sep 30; 169(2):124-31. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S. PMID: 19712979.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    87. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res. 2009 Sep 30; 169(2):132-8. Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S. PMID: 19709754.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    88. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009 Aug; 29(4):372-7. Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. PMID: 19593178.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    89. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. J Psychiatr Res. 2010 Jan; 44(2):90-8. Hunter AM, Muthén BO, Cook IA, Leuchter AF. PMID: 19631948; PMCID: PMC2925497.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    90. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol. 2009 Jul; 120(7):1313-9. Korb AS, Hunter AM, Cook IA, Leuchter AF. PMID: 19539524; PMCID: PMC2710394.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    91. Painful physical symptoms and treatment outcome in major depressive disorder: a STAR*D (Sequenced Treatment Alternatives to Relieve Depression) report. Psychol Med. 2010 Feb; 40(2):239-51. Leuchter AF, Husain MM, Cook IA, Trivedi MH, Wisniewski SR, Gilmer WS, Luther JF, Fava M, Rush AJ. PMID: 19493369.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    92. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Med. 2009 May-Jun; 10(4):730-8. Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE, Chappell AS. PMID: 19453962.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clin EEG Neurosci. 2009 Apr; 40(2):78-83. Leuchter AF, Cook IA, Hunter A, Korb A. PMID: 19534301.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    94. A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci. 2009; 11(4):435-46. Leuchter AF, Cook IA, Hunter AM, Korb AS. PMID: 20135901; PMCID: PMC3181929.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimals
    95. Quantitative EEG abnormalities are associated with memory impairment in recently abstinent methamphetamine-dependent individuals. J Neuropsychiatry Clin Neurosci. 2009; 21(3):254-8. Kalechstein AD, De la Garza R, Newton TF, Green MF, Cook IA, Leuchter AF. PMID: 19776303; PMCID: PMC3350803.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    96. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatr Scand. 2009 Apr; 119(4):266-73. Hunter AM, Ravikumar S, Cook IA, Leuchter AF. PMID: 19077131.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    97. Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr. 2008 Dec; 21(2):138-46. Korb AS, Cook IA, Hunter AM, Leuchter AF. PMID: 18958615.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    98. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clin EEG Neurosci. 2008 Oct; 39(4):175-81. Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. PMID: 19044214.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    99. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder. J Psychiatr Pract. 2008 Sep; 14(5):271-80. Leuchter AF, Lesser IM, Trivedi MH, Rush AJ, Morris DW, Warden D, Fava M, Wisniewski SR, Luther JF, Perales M, Gaynes BN, Stewart JW. PMID: 18832958; PMCID: PMC2778329.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    100. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008 Mar; 165(3):342-51. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH. PMID: 18172020.
      View in: PubMed   Mentions: 248     Fields:    Translation:Humans
    101. Yoga as a complementary treatment of depression: effects of traits and moods on treatment outcome. Evid Based Complement Alternat Med. 2007 Dec; 4(4):493-502. Shapiro D, Cook IA, Davydov DM, Ottaviani C, Leuchter AF, Abrams M. PMID: 18227917; PMCID: PMC2176141.
      View in: PubMed   Mentions: 69  
    102. Need to strike balance with industry-academia rules. Nature. 2007 Oct 11; 449(7163):658. Leuchter A, Levey GS. PMID: 17928837.
      View in: PubMed   Mentions:    Fields:    
    103. Aging and brain activation with working memory tasks: an fMRI study of connectivity. Int J Geriatr Psychiatry. 2007 Apr; 22(4):332-42. Cook IA, Bookheimer SY, Mickes L, Leuchter AF, Kumar A. PMID: 17236244.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    104. Insured and non-insured depressed outpatients: how do they compare? Ann Clin Psychiatry. 2007 Apr-Jun; 19(2):73-82. Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Fava M, Rush AJ. PMID: 17612846.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    105. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am. 2007 Mar; 30(1):105-24. Hunter AM, Cook IA, Leuchter AF. PMID: 17362807.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    106. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. Am J Psychiatry. 2006 Aug; 163(8):1426-32. Hunter AM, Leuchter AF, Morgan ML, Cook IA. PMID: 16877657.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    107. Neurophysiologic changes during estrogen augmentation in perimenopausal depression. Maturitas. 2007 Jan 20; 56(1):54-60. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. PMID: 16835012.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    108. Clinical differences among depressed patients with and without a history of suicide attempts: findings from the STAR*D trial. J Affect Disord. 2007 Jan; 97(1-3):77-84. Claassen CA, Trivedi MH, Rush AJ, Husain MM, Zisook S, Young E, Leuchter A, Wisniewski SR, Balasubramani GK, Alpert J. PMID: 16824617.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    109. Does the clinical course of depression determine improvement in symptoms and quality of life? J Nerv Ment Dis. 2006 Apr; 194(4):241-8. Moses T, Leuchter AF, Cook I, Abrams M. PMID: 16614544.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    110. Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: predicting cocaine-dependent treatment attrition. J Neuropsychiatry Clin Neurosci. 2006; 18(2):208-16. Venneman S, Leuchter A, Bartzokis G, Beckson M, Simon SL, Schaefer M, Rawson R, Newton T, Cook IA, Uijtdehaage S, Ling W. PMID: 16720798.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    111. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics. 2005 Sep-Oct; 46(5):379-84. Krell HV, Leuchter AF, Cook IA, Abrams M. PMID: 16145181.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    112. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res. 2005 Sep; 39(5):461-6. Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. PMID: 15992554.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    113. Characteristics of insured and noninsured outpatients with depression in STAR(*)D. Psychiatr Serv. 2005 Aug; 56(8):995-1004. Lesser IM, Leuchter AF, Trivedi MH, Davis LL, Wisniewski SR, Balasubramani GK, Petersen T, Stegman D, Rush AJ. PMID: 16088018.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    114. Influence of age, gender, health status, and depression on quantitative EEG. Neuropsychobiology. 2005; 52(2):71-6. Morgan ML, Witte EA, Cook IA, Leuchter AF, Abrams M, Siegman B. PMID: 15990459.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    115. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry. 2005 Jun; 66(6):774-80. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. PMID: 15960574.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    116. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology. 2005 Apr; 30(4):792-9. Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. PMID: 15637637.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    117. Subject expectations of treatment effectiveness and outcome of treatment with an experimental antidepressant. J Clin Psychiatry. 2004 Sep; 65(9):1174-9. Krell HV, Leuchter AF, Morgan M, Cook IA, Abrams M. PMID: 15367043.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    118. Pretreatment neurophysiologic function and ECT response in depression. J ECT. 2004 Sep; 20(3):142-4. Stubbeman WF, Leuchter AF, Cook IA, Shurman BD, Morgan M, Gunay I, Gonzalez S. PMID: 15342997.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    119. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl). 2004 Dec; 177(1-2):15-22. Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. PMID: 15252704.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    120. Predictors of improved mood over time in clinical trials for major depression. Psychiatry Res. 2004 Jun 30; 127(1-2):73-84. Marie-Mitchell A, Leuchter AF, Chou CP, James Gauderman W, Azen SP. PMID: 15261707.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    121. Longitudinal progression of subclinical structural brain disease in normal aging. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):190-200. Cook IA, Leuchter AF, Morgan ML, Dunkin JJ, Witte E, David S, Mickes L, O'Hara R, Simon S, Lufkin R, Abrams M, Rosenberg S. PMID: 15010348.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    122. Association between quantitative EEG and neurocognition in methamphetamine-dependent volunteers. Clin Neurophysiol. 2004 Jan; 115(1):194-8. Newton TF, Kalechstein AD, Hardy DJ, Cook IA, Nestor L, Ling W, Leuchter AF. PMID: 14706488.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    123. Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol. 2003 Mar; 114(3):410-5. Newton TF, Cook IA, Kalechstein AD, Duran S, Monroy F, Ling W, Leuchter AF. PMID: 12705421.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    124. Cognitive and physiologic correlates of subclinical structural brain disease in elderly healthy control subjects. Arch Neurol. 2002 Oct; 59(10):1612-20. Cook IA, Leuchter AF, Morgan ML, Conlee EW, David S, Lufkin R, Babaie A, Dunkin JJ, O'Hara R, Simon S, Lightner A, Thomas S, Broumandi D, Badjatia N, Mickes L, Mody RK, Arora S, Zheng Z, Abrams M, Rosenberg-Thompson S. PMID: 12374500.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    125. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry. 2002 Jul; 17(7):610-8. Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. PMID: 12112157.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    126. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002 Jul; 27(1):120-31. Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH. PMID: 12062912.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    127. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry. 2002 Jan; 159(1):122-9. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. PMID: 11772700.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCTClinical Trials
    128. Prefrontal changes and treatment response prediction in depression. Semin Clin Neuropsychiatry. 2001 Apr; 6(2):113-20. Cook IA, Leuchter AF. PMID: 11296311.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    129. Executive dysfunction predicts nonresponse to fluoxetine in major depression. J Affect Disord. 2000 Oct; 60(1):13-23. Dunkin JJ, Leuchter AF, Cook IA, Kasl-Godley JE, Abrams M, Rosenberg-Thompson S. PMID: 10940443.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    130. Attenuation of brain high frequency electrocortical response after thiopental in early stages of Alzheimer's dementia. Psychopharmacology (Berl). 2000 Mar; 149(1):6-11. Holschneider DP, Leuchter AF. PMID: 10789876.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    131. Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin. Exp Brain Res. 1999 May; 126(2):270-80. Holschneider DP, Waite JJ, Leuchter AF, Walton NY, Scremin OU. PMID: 10369149; PMCID: PMC4134916.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    132. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res. 1999 Apr 26; 90(2):125-40. Leuchter AF, Uijtdehaage SH, Cook IA, O'Hara R, Mandelkern M. PMID: 10482384.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    133. Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res. 1999 Mar 22; 85(3):263-73. Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ. PMID: 10333379.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    134. EEG abnormalities in nonmedicated panic disorder. J Nerv Ment Dis. 1999 Feb; 187(2):113-4. Bystritsky A, Leuchter AF, Vapnik T. PMID: 10067952.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    135. Clinical neurophysiology using electroencephalography in geriatric psychiatry: neurobiologic implications and clinical utility. J Geriatr Psychiatry Neurol. 1999; 12(3):150-64. Holschneider DP, Leuchter AF. PMID: 10593703.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    136. Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr Clin Neurophysiol. 1998 Dec; 107(6):408-14. Cook IA, O'Hara R, Uijtdehaage SH, Mandelkern M, Leuchter AF. PMID: 9922086.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    137. Altered cerebral energy utilization in late life depression. J Affect Disord. 1998 May; 49(2):89-99. Cook IA, Leuchter AF, Uijtdehaage SH, Osato S, Holschneider DH, Abrams M, Rosenberg-Thompson S. PMID: 9609672.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    138. Effects of cholinergic deafferentation and NGF on brain electrical coherence. Brain Res Bull. 1998 Mar 15; 45(5):531-41. Holschneider DP, Leuchter AF, Scremin OU, Treiman DM, Walton NY. PMID: 9570724.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    139. Changes in cortical EEG and cholinergic function in response to NGF in rats with nucleus basalis lesions. Brain Res. 1997 Aug 15; 765(2):228-37. Holschneider DP, Leuchter AF, Walton NY, Scremin OU, Treiman DM. PMID: 9313895.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    140. Loss of high-frequency brain electrical response to thiopental administration in Alzheimer's-type dementia. Neuropsychopharmacology. 1997 Apr; 16(4):269-75. Holschneider DP, Leuchter AF, Uijtdehaage SH, Abrams M, Rosenberg-Thompson S. PMID: 9094144.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    141. Brain structure and function and the outcomes of treatment for depression. J Clin Psychiatry. 1997; 58 Suppl 16:22-31. Leuchter AF, Cook IA, Uijtdehaage SH, Dunkin J, Lufkin RB, Anderson-Hanley C, Abrams M, Rosenberg-Thompson S, O'Hara R, Simon SL, Osato S, Babaie A. PMID: 9430506.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    142. EEG power correlates with subcortical metabolic activity in AIDS. J Neuropsychiatry Clin Neurosci. 1997; 9(4):574-8. Newton TF, Leuchter AF, van Gorp WG, Hinkin CH, Mandelkern M, Weiner H. PMID: 9447499.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    143. Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG. Behav Brain Res. 1996 Jun; 78(1):15-23. Cook IA, Leuchter AF. PMID: 8793033.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    144. Quantitative EEG in frontotemporal dementia. Clin Electroencephalogr. 1996 Apr; 27(2):61-8. Yener GG, Leuchter AF, Jenden D, Read SL, Cummings JL, Miller BL. PMID: 8681464.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    145. Beta activity in aging and dementia. Brain Topogr. 1995; 8(2):169-80. Holschneider DP, Leuchter AF. PMID: 8793127.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    146. Relationships between EEG coherence and neuropsychological tests in dementia. Clin Electroencephalogr. 1995 Jan; 26(1):47-59. Dunkin JJ, Osato S, Leuchter AF. PMID: 7882542.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    147. Effect of white matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry. 1994 Nov; 57(11):1347-54. Leuchter AF, Dunkin JJ, Lufkin RB, Anzai Y, Cook IA, Newton TF. PMID: 7964810; PMCID: PMC1073185.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    148. Electroencephalographic coherence in acquired immune deficiency syndrome. Psychiatry Res. 1994 Oct; 54(1):1-11. Newton TF, Leuchter AF, Walter DO, van Gorp WG, Morgenstern H, Miller EN, Lieb K, Visscher B, Satz P, Weiner H. PMID: 7701024.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    149. Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res. 1994 Sep; 55(3):141-52. Leuchter AF, Cook IA, Mena I, Dunkin JJ, Cummings JL, Newton TF, Migneco O, Lufkin RB, Walter DO, Lachenbruch PA. PMID: 7870854.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    150. Reduced EEG coherence in dementia: state or trait marker? Biol Psychiatry. 1994 Jun 01; 35(11):870-9. Dunkin JJ, Leuchter AF, Newton TF, Cook IA. PMID: 8054410.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    151. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage. 1994 Jun; 1(3):208-19. Leuchter AF, Cook IA, Lufkin RB, Dunkin J, Newton TF, Cummings JL, Mackey JK, Walter DO. PMID: 9343572.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    152. Quantitative EEG in patients with AIDS and asymptomatic HIV infection. Clin Electroencephalogr. 1994 Jan; 25(1):18-25. Newton TF, Leuchter AF, Miller EN, Weiner H. PMID: 8174287.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    153. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroencephalogr Clin Neurophysiol. 1993 Dec; 87(6):385-93. Leuchter AF, Cook IA, Newton TF, Dunkin J, Walter DO, Rosenberg-Thompson S, Lachenbruch PA, Weiner H. PMID: 7508371.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    154. Serial quantitative EEG among elderly subjects with delirium. Biol Psychiatry. 1993 Aug 01; 34(3):135-40. Jacobson SA, Leuchter AF, Walter DO, Weiner H. PMID: 8399804.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    155. Prevalence and significance of electroencephalographic abnormalities in patients with suspected organic mental syndromes. J Am Geriatr Soc. 1993 Jun; 41(6):605-11. Leuchter AF, Daly KA, Rosenberg-Thompson S, Abrams M. PMID: 8505456.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    156. Clinical, neuroimaging, and environmental risk differences in monozygotic female twins appearing discordant for dementia of the Alzheimer type. Arch Neurol. 1993 Feb; 50(2):209-19. Small GW, Leuchter AF, Mandelkern MA, La Rue A, Okonek A, Lufkin RB, Jarvik LF, Matsuyama SS, Bondareff W. PMID: 8431141.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    157. Conventional and quantitative EEG in the diagnosis of delirium among the elderly. J Neurol Neurosurg Psychiatry. 1993 Feb; 56(2):153-8. Jacobson SA, Leuchter AF, Walter DO. PMID: 8437004; PMCID: PMC1014814.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    158. EEG coherence in men with AIDS: association with subcortical metabolic activity. J Neuropsychiatry Clin Neurosci. 1993; 5(3):316-21. Newton TF, Leuchter AF, Walter DO, Van Gorp WC, Stern CE, Mandelkern M, Weiner H. PMID: 8369642.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    159. Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain. 1992 Oct; 115 ( Pt 5):1543-61. Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA. PMID: 1422803.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    160. Falling backward in two elderly patients taking bupropion. J Clin Psychiatry. 1992 May; 53(5):157-9. Szuba MP, Leuchter AF. PMID: 1592841.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    161. Stable bimodal response to cholinomimetic drugs in Alzheimer's disease. Brain mapping correlates. Neuropsychopharmacology. 1991 May; 4(3):165-73. Leuchter AF, Read SL, Shapira J, Walter DO, Smith C. PMID: 1676588.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    162. Quantitative measurement of brain electrical activity in delirium. Int Psychogeriatr. 1991; 3(2):231-47. Leuchter AF, Jacobson SA. PMID: 1811776.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    163. Diagnosis and assessment of dementia using functional brain imaging. Int Psychogeriatr. 1989; 1(1):63-72. Leuchter AF, Walter DO. PMID: 2490905.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    164. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study. Arch Gen Psychiatry. 1987 Nov; 44(11):993-8. Leuchter AF, Spar JE, Walter DO, Weiner H. PMID: 3314770.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    165. The late-onset psychoses. Clinical and diagnostic features. J Nerv Ment Dis. 1985 Aug; 173(8):488-94. Leuchter AF, Spar JE. PMID: 2862222.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans